Copertina

Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Maggie R. Mittleman, Elizabeth Mostofsky, Angeliki Vgontzas, Suzanne M. Bertisch
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Headache: The Journal of Head and Face Pain
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Waning light, waxing pain: The lunar cycle's association with migraine headache occurrence
di: Alexander Yoo, et al.
Pubblicazione: (2025)

Chronotype in migraine and tension‐type headache: A population study
di: Da Eun Jung, et al.
Pubblicazione: (2026)

Magnetoencephalography studies in migraine and headache disorders: A systematic review
di: Raghavan Gopalakrishnan, et al.
Pubblicazione: (2024)

Persistent headache attributed to past ischemic stroke: A prospective cohort study
di: Felipe A. A. de Oliveira, et al.
Pubblicazione: (2024)

Maternal and child mental health and incident migraine in adolescence: An “All Our Families” prospective cohort study
di: Kirsten Sjonnesen, et al.
Pubblicazione: (2026)

The impact of headache intensity on speech in participants with migraine and acute post‐traumatic headache
di: Dani C. Smith, et al.
Pubblicazione: (2024)

Lifestyle triggers of migraine: Sleep restriction and caffeine lower the threshold for migraine‐like responses in rats in a sex‐specific manner
di: Gabriel Camargo de Oliveira, et al.
Pubblicazione: (2026)

Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
di: Shuu‐Jiun Wang, et al.
Pubblicazione: (2024)

A study of migraine‐like headache caused by topical aryl hydrocarbon receptor agonist tapinarof
di: Toshiyuki Hikita, et al.
Pubblicazione: (2026)

Flexible modeling of headache frequency fluctuations in migraine with hidden Markov models
di: Gina M. Dumkrieger, et al.
Pubblicazione: (2024)

Patient satisfaction with calcitonin gene‐related peptide monoclonal antibodies in migraine: A multicenter prospective cohort study
di: Alba López‐Bravo, et al.
Pubblicazione: (2025)

Insomnia severity in migraine: The role of headache frequency, aura status, and comorbidities—A cross‐sectional study
di: Kuang‐Heng Lee, et al.
Pubblicazione: (2025)

Effectiveness and acceptability of oral migraine preventives: A prospective, observational study
di: Hedda S. Riise, et al.
Pubblicazione: (2026)

Metaphorical use of “headache” and “migraine” in media: A longitudinal study of 1.3 million articles in major publications
di: Pengfei Zhang, et al.
Pubblicazione: (2024)

Preliminary prospective observational investigation of clinical outcomes among treatment‐seeking youth with continuous headache
di: Robert C. Gibler, et al.
Pubblicazione: (2024)

Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache
di: Andrew Blumenfeld, et al.
Pubblicazione: (2024)

Youth with high‐frequency headaches due to migraine are more vulnerable to non‐cephalic pain complaints
di: Brooke L. Reidy, et al.
Pubblicazione: (2025)

Case report: Prophylactic administration of verapamil for cluster headache during the pre‐episode symptoms phase
di: Yajin Wu, et al.
Pubblicazione: (2025)

Identifying and predicting headache trajectories among those with acute post‐traumatic headache
di: Lingchao Mao, et al.
Pubblicazione: (2025)

Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders—A retrospective tolerability and safety study
di: Christopher C. Anderson, et al.
Pubblicazione: (2024)

Plain Language Summary Publication: The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American headache society evidence assessment of parenteral pharmacotherapies
di: Jennifer Robblee, et al.
Pubblicazione: (2024)

Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine
di: Jessica Ailani, et al.
Pubblicazione: (2024)

Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete‐choice experiment
di: Richard B. Lipton, et al.
Pubblicazione: (2025)

Clinical factors associated with day‐to‐day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data
di: Marina Vives‐Mestres, et al.
Pubblicazione: (2024)

Patient preferences for preventive migraine treatments among Canadian adults: A discrete choice experiment
di: Joanna K. Bougie, et al.
Pubblicazione: (2024)

Comprehensive assessment of erenumab efficacy in participants with high‐frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study
di: Gabriel Paiva da Silva Lima, et al.
Pubblicazione: (2025)

Epidemiology and characteristics of status migrainosus in a tertiary headache clinic: A retrospective cohort study
di: Evelyn Dorsey, et al.
Pubblicazione: (2026)

Heightened migraine risk in patients with rheumatoid arthritis: A national retrospective cohort study
di: Seonyoung Kang, et al.
Pubblicazione: (2024)

Characterization of insomnia and sleep quality in a cohort with cluster headache
di: Felicia Jennysdotter Olofsgård, et al.
Pubblicazione: (2025)

A multicenter, prospective, single‐arm study of 60‐day peripheral nerve stimulation of the occipital nerves for the treatment of headache
di: Genaro G. Gutierrez, et al.
Pubblicazione: (2025)

Identifying cognitive‐affective mechanisms underlying disability in episodic migraine: Using the fear avoidance model to examine interactions
di: Janosch Fox, et al.
Pubblicazione: (2025)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
di: Rikki Mangrum, et al.
Pubblicazione: (2024)

A critical appraisal of the International Classification of Headache Disorders migraine diagnostic criteria based on a retrospective multicenter cross‐sectional headache registry study in youth
di: Carlyn Patterson Gentile, et al.
Pubblicazione: (2024)

Effectiveness of switching strategies in CGRP monoclonal antibody therapy for migraine: A retrospective cohort study
di: Alex Jaimes, et al.
Pubblicazione: (2024)

Exploring the relationship between pain catastrophizing and migraine in youth: A longitudinal clinical cohort study
di: Alexis Espanioli, et al.
Pubblicazione: (2025)

Exploring the impact of acute SARS‐CoV‐2 infection on headache pattern in patients with migraine: A novel Bayesian analysis
di: Jiunn‐Tyng Yeh, et al.
Pubblicazione: (2025)

Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐blind, placebo‐controlled trial
di: Muneto Tatsumoto, et al.
Pubblicazione: (2024)

Changes in brainstem habituation during onabotulinumtoxinA treatment in chronic migraine: A prospective case–control study
di: Gerlinde Freimark, et al.
Pubblicazione: (2025)

Association between obstructive sleep apnea and migraine: A United States population‐based cohort study
di: Thomas Yen‐Ting Chen, et al.
Pubblicazione: (2025)

Characteristics of men and women with medically diagnosed cluster headache in a national integrated healthcare system: A Veterans Health Administration cohort study
di: Elizabeth K. Seng, et al.
Pubblicazione: (2024)